Delivery Order SPE2DR25D6028-SPE2DR26FASEM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,005.54 to AmerisourceBergen Drug Corp for the supply of Oseltamivir 75mg (10-count units) on November 7, 2025, with completion scheduled for December 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment of pharmaceutical supply needs under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,016.96 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This competitively awarded, firm fixed-price contract carries a ceiling value of $3,699.10 and is scheduled for completion by September 25, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 tablets, with a ceiling value of $59,932.80 and an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Oseltamivir, an antiviral medication...
- The Defense Logistics Agency awarded a delivery order valued at $2,801.29 to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml suspension in 60ml quantities. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of October 24, 2025. The award was issued on October 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Oseltamivir is an antiviral medication...
- The Defense Logistics Agency awarded a $7,491.60 delivery order to AmerisourceBergen Drug Corp for oseltamivir phosphate 75 mg capsules in unit dose packaging (10 count) on December 8, 2025, with a completion date of December 9, 2025. This non-compete, firm fixed-price delivery order represents a continuation of pharmaceutical supply under a larger contract vehicle supporting federal medical procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,298.88 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The award was competitively executed and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- This delivery order, awarded December 5, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, covers the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract carries a ceiling value of $3,648.12 with a firm fixed price structure and an ultimate completion date of December 8, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and...
- This federal contract award is a delivery order valued at $1,494.60 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,563,471,961 units of the drug Oseltamivir Phosphate 75 mg capsules, an antiviral medication used to treat and prevent influenza. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. It is a firm fixed-price contract with no set-aside...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASEMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,716.94 to AmerisourceBergen Drug Corp for the supply of Oseltamivir 75mg in unit dose packages of 10 units. This is a firm fixed price, non-set-aside contract with a completion date of December 30, 2025, and was awarded on December 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Oseltamivir is an antiviral medication commonly used for influenza treatment and prevention, representing part of the pharmaceutical supply chain supporting federal healthcare operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs and other federal health systems. AmerisourceBergen's continued success in securing competitive awards reflects its established capability as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly within the Defense Health Agency and military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 12/1/25 |